within Pharmacolibrary.Drugs.ATC.V;

model V04CX06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Hexaminolevulinate is a photosensitizing agent used in the detection of bladder cancer, specifically for photodynamic diagnosis of non-muscle invasive bladder cancer during cystoscopy. It is approved and marketed for intravesical administration for this diagnostic purpose.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for hexaminolevulinate after intravesical instillation in adult patients undergoing diagnostic cystoscopy for bladder cancer; no systemic absorption expected in healthy individuals.</p><h4>References</h4><ol><li><p>Klem, B, et al., &amp; Garner, RC (2006). Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers. <i>Journal of clinical pharmacology</i> 46(4) 456–460. DOI:<a href=&quot;https://doi.org/10.1177/0091270006286849&quot;>10.1177/0091270006286849</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16554454/&quot;>https://pubmed.ncbi.nlm.nih.gov/16554454</a></p></li><li><p>Vandepitte, J, et al., &amp; de Witte, PA (2011). Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder. <i>Cancer chemotherapy and pharmacology</i> 67(4) 775–781. DOI:<a href=&quot;https://doi.org/10.1007/s00280-010-1375-0&quot;>10.1007/s00280-010-1375-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20532886/&quot;>https://pubmed.ncbi.nlm.nih.gov/20532886</a></p></li><li><p>François, A, et al., &amp; D&#x27;Hallewin, MA (2012). Fluorescence diagnosis of bladder cancer: a novel in vivo approach using 5-aminolevulinic acid (ALA) dendrimers. <i>BJU international</i> 110(11 Pt C) E1155–E1162. DOI:<a href=&quot;https://doi.org/10.1111/j.1464-410X.2012.11407.x&quot;>10.1111/j.1464-410X.2012.11407.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22883132/&quot;>https://pubmed.ncbi.nlm.nih.gov/22883132</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V04CX06;
